Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer

Peer review reports

Original Submission
15 Oct 2020	Submitted	Original manuscript
30 Oct 2020	Reviewed	Reviewer Report
2 Dec 2020	Reviewed	Reviewer Report
16 Dec 2020	Author responded	Author comments - Adrien Guilloteau
Resubmission - Version 2
16 Dec 2020	Submitted	Manuscript version 2
Publishing
21 Dec 2020	Editorially accepted
9 Jan 2021	Article published	10.1186/s12874-020-01202-9

Back to article page